ArticleChild psychiatry and human development2023
Psychometric Evaluation of the Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder for Adolescents (BDD-YBOCS-A).
Article in Child psychiatry and human development, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Empirically informed symptom severity cutoffs for body dysmorphic disorder.Journal of psychiatric research · 2025Pooled it
- Developmentally Tailored Telehealth-Delivered Cognitive-Behavioural Therapy for Adolescents with Body Dysmorphic Disorder: A Multiple Baseline Design.Research on child and adolescent psychopathology · 2026Trial
- Efficacy of an internet-based, therapist-guided cognitive behavioral therapy intervention for adolescents and young adults with body dysmorphic disorder: a randomized controlled trial.BMC psychiatry · 2025Trial
- Article
- A Psychometric Evaluation of the Body Image Questionnaire Child and Adolescent Version.Child psychiatry and human development · 2026Article
- Psycho Dermatological Dimensions of Body Dysmorphic Disorder: A Comprehensive Review of Diagnostic Criteria, Treatment Options, and Clinical Outcomes in Dermatological and Cosmetic Surgery Settings.Aesthetic plastic surgery · 2026Review
- Preoperative Screening for Body Dysmorphic Disorder in Facial Plastic Surgery: Protocol Development and Validation.Aesthetic plastic surgery · 2026Article
- Cosmeticorexia in Adolescence: A Case Report and Psychodynamic Formulation.Psychology research and behavior management · 2026Article
- Body Dysmorphic Disorder and Risperidone Abuse: Exploiting Hyperprolactinemia.Journal of the Korean Academy of Child and Adolescent Psychiatry · 2025Article
- Body dysmorphic disorder.Nature reviews. Disease primers · 2024Review
- Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder: Factor Structure and Construct Validity of Subfactors.Journal of obsessive-compulsive and related disorders · 2024Article
- Therapist-guided, Internet-delivered cognitive behaviour therapy for adolescents with body dysmorphic disorder: A feasibility trial with long-term follow-up.Internet interventions · 2023Article
- Prevalence of body dysmorphic disorder in rhinoplasty candidates: A systematic review and meta-analysis.Health science reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder for Adolescents (BDD-YBOCS-A) is a clinician-rated measure of BDD symptom severity in youth. Despite widespread use in both research and clinical practice, its psychometric properties have not been formally evaluated. The current study examined the factor structure, reliability, validity, and sensitivity to change of the BDD-YBOCS-A in 251 youths with BDD attending two specialist clinics. A principal component analysis identified two factors, explaining 56% of the variance. The scale showed good internal consistency (Cronbach's alpha = 0.87) and adequate convergent and divergent validity. In a subgroup of participants receiving BDD treatment (n = 175), BDD-YBOCS-A scores significantly decreased over time, demonstrating sensitivity to change. BDD-YBOCS-A change scores over treatment were highly correlated with severity changes measured by the Clinical Global Impression - Severity scale (r = .84). The study provides empirical support for the use of the BDD-YBOCS-A in children and adolescents with BDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.